Midgard Science
SB

Systasy Bioscience GmBH

Munich, Germany systasy.de From their website, Nov 2026

Work here? Claim this listing

About

Systasy Bioscience GmbH provides hyper-multiplexed drug discovery solutions for complex diseases, with a focus on brain disorders, for pharmaceutical and biotech partners. It also offers patient-derived human disease models, pathway-based screening, viral tropism profiling for gene therapy development, and single-cell/nucleus RNA sequencing services. The company is headquartered in Munich/Planegg, Germany.

Services

  • Pathway Based Drug Discovery

    Uses highly multiplexed pathway activity screens with patient-derived human disease models to identify disease pathways, therapeutic targets, and support hit identification and lead optimization.

  • targetFinder

    Combines RNAi or CRISPR/Cas9 libraries with optimized sensors to measure the roles of individual genes in signaling networks.

  • pathwayPROFILER

    Measures the activities of various disease-relevant target classes in living cells.

  • safetyProfiler

    A multiplexed cell-based assay platform for drug safety profiling that reveals efficacy, potency, and side effects of drugs.

  • Single-Cell/Nucleus RNA Sequencing

    Provides an end-to-end workflow from sample processing and library preparation through sequencing, data analysis, and reporting.

    Genomics & sequencing

  • Human Disease Models

    Develops and uses patient-derived human disease models for multiplexed pathway analysis and compound screening.

  • Viral Tropism profiling

    Offers profiling technology to support viral vector development for gene therapy.

  • Barcoding Technology

    Uses proprietary DNA barcoding technology for highly multiplexed transcriptomic and pathway analysis at the single-cell level.

1 more services
  • Single-Cell Transcriptomics
What to send
  • Sample processing from complex and difficult-to-dissociate tissues
  • Cells or nuclei for single-cell/single-nucleus workflows

Capabilities

Assays and studies
  • NGS
  • High-content imaging
  • Cell-based assays
  • Multiplexed pathway activity screens
  • Drug safety profiling
  • Phenotypic screening
13 more
  • Mechanism-of-action (MOA) analysis
  • Compound screening
  • Lead optimization
  • Dose-response profiling
  • Single-cell RNA-seq
  • Single-nucleus RNA sequencing
  • Transcriptomic analysis
  • Highly multiplexed pathway activity screens
  • High-content phenotypic profiling
  • Single-cell RNA sequencing
  • Viral tropism profiling
  • Biomarker identification
  • Patient stratification
Scale and capacity
  • Up to 30 major cellular signaling pathways captured in parallel
  • Millions of molecular barcodes
  • More than 100 individual signaling events
  • Seven major signaling clusters
Therapeutic areas
  • Brain disorders
  • Neutrophil-derived inflammatory diseases
  • Neuroscience
  • Cancer
  • Immunology
  • Developmental biology

Instruments and platforms

  • Next-generation sequencing (NGS) platforms

Modalities and species

Modalities
  • Viral vector
  • Cell therapy
  • Gene editing
Species and models
  • Human disease models
  • Human neuronal 2D models
  • Human 3D models
  • Cell lines
  • Murine models
  • iPSC-based human disease models
7 more
  • Patient-derived cellular model systems
  • Neuroscience
  • Cancer
  • Immunology
  • Developmental biology
  • Patient-derived human disease models
  • Cell-based assays

Industries served

  • Pharmaceutical
  • Biotech
  • Gene therapy

Details

Founded
2012
Office
Fraunhoferstraße 8, 82152 Planegg
Sites
  • Planegg, Germany
  • Martinsreid, Germany
  • Göttingen, Germany
Phone
+49 (0) 89 - 9442 5775

Similar labs